UBS Group’s Tiziana Life Sciences TLSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78K | Sell |
4,289
-610
| -12% | -$964 | ﹤0.01% | 7740 |
|
|
2025
Q1 | $5.29K | Hold |
4,899
| – | – | ﹤0.01% | 7698 |
|
|
2024
Q4 | $3.41K | Buy |
4,899
+4,289
| +703% | +$2.99K | ﹤0.01% | 7639 |
|
|
2024
Q3 | $586 | Sell |
610
-51,007
| -99% | -$49K | ﹤0.01% | 7659 |
|
|
2024
Q2 | $47.4K | Buy |
51,617
+19,763
| +62% | +$18.2K | ﹤0.01% | 5585 |
|
|
2024
Q1 | $14.5K | Buy |
31,854
+3,295
| +12% | +$1.5K | ﹤0.01% | 5896 |
|
|
2023
Q4 | $16K | Buy |
28,559
+27,849
| +3,922% | +$15.6K | ﹤0.01% | 6031 |
|
|
2023
Q3 | $469 | Buy |
710
+90
| +15% | +$59 | ﹤0.01% | 7327 |
|
|
2023
Q2 | $422 | Sell |
620
-5,592
| -90% | -$3.81K | ﹤0.01% | 7158 |
|
|
2023
Q1 | $6.78K | Sell |
6,212
-13,544
| -69% | -$14.8K | ﹤0.01% | 6787 |
|
|
2022
Q4 | $11.9K | Sell |
19,756
-1,987
| -9% | -$1.19K | ﹤0.01% | 7155 |
|
|
2022
Q3 | $16K | Buy |
21,743
+16,313
| +300% | +$12K | ﹤0.01% | 6612 |
|
|
2022
Q2 | $4K | Buy |
5,430
+4,557
| +522% | +$3.36K | ﹤0.01% | 8089 |
|
|
2022
Q1 | $1K | Sell |
873
-1,789
| -67% | -$2.05K | ﹤0.01% | 8869 |
|
|
2021
Q4 | $3K | Sell |
2,662
-705
| -21% | -$795 | ﹤0.01% | 8566 |
|
|
2021
Q3 | $5K | Buy |
3,367
+2,089
| +163% | +$3.1K | ﹤0.01% | 7408 |
|
|
2021
Q2 | $3K | Buy |
+1,278
| New | +$3K | ﹤0.01% | 7729 |
|
|
2020
Q4 | – | Sell |
-1,401
| Closed | -$5K | – | 7633 |
|
|
2020
Q3 | $5K | Buy |
+1,401
| New | +$5K | ﹤0.01% | 6455 |
|
|
2019
Q2 | – | Sell |
-7,552
| Closed | -$9K | – | 7146 |
|
|
2019
Q1 | $9K | Sell |
7,552
-3,499
| -32% | -$4.17K | ﹤0.01% | 6052 |
|
|
2018
Q4 | $16K | Buy |
+11,051
| New | +$16K | ﹤0.01% | 6030 |
|